Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | CATXPerspective Therapeutics, Inc.FY2023 · Dec |
|---|---|
| Revenue | $1.43M |
| Revenue, yoy | — |
| Net income | $103.12M |
| Net income, yoy | −30.1% |
| Net margin | — |
| Free cash flow | $95.23M |
| FCF margin | — |
| EPS, diluted | $1.40 |
Add another company.